Back to Atlas
CTransientStandard research/education caution
CMP-0332
Experimental
Fluoromodafinil
Eugeroic
Wakefulness, vigilance and fatigue reduction
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Small molecule
- Primary mechanism
- Modafinil analog; wakefulness-promoting catecholaminergic effects
- Primary market use
- Wakefulness / productivity
Pharmacology
- Molecular weight (Da)
- 291.3
- Oral bioavailability
- Likely oral; unknown
- Half-life
- ~10-15 h
- Route tags
- Route-dependent / verify
- Evidence level
- Limited human/Research
- Clinical status
- Experimental
- Value-for-money score
- 5 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Transient eugeroic effect